# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-006984
Filing Date
2025-01-27
Accepted
2025-01-27 16:05:15
Documents
17
Period of Report
2025-03-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea022803801-def14a_citius.htm iXBRL | DEF 14A | 516106
2 | GRAPHIC | image_001.jpg | GRAPHIC | 86775
3 | GRAPHIC | image_002.jpg | GRAPHIC | 170533
4 | GRAPHIC | image_003.jpg | GRAPHIC | 292743
| Complete submission text file | 0001213900-25-006984.txt |  | 2642529

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ctxr-20250117.xsd | EX-101.SCH | 11035
6 | XBRL DEFINITION FILE | ctxr-20250117_def.xml | EX-101.DEF | 5394
7 | XBRL LABEL FILE | ctxr-20250117_lab.xml | EX-101.LAB | 36773
8 | XBRL PRESENTATION FILE | ctxr-20250117_pre.xml | EX-101.PRE | 7764
19 | EXTRACTED XBRL INSTANCE DOCUMENT | ea022803801-def14a_citius_htm.xml | XML | 206104

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 25559031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)